Epidemiology and Economic Burden of Sleep Disorders in Europe - PubMed
7 days ago
- #sleep disorders
- #economic burden
- #epidemiology
- Sleep disorders (SD) significantly impact brain, body, and societal health, but their epidemiological and economic burden is understudied.
- This study examines the epidemiology and costs of SD across 47 European countries, focusing on insomnia, OSA, narcolepsy, RLS, and RBD.
- Prevalence rates in adults: OSA (18%), insomnia (10%), RLS (3%), narcolepsy (0.03%), and RBD (0.009%).
- Economic burden is highest for OSA (€184 billion), followed by insomnia (€158 billion), RLS (€79 billion), narcolepsy (€905 million), and RBD (€436 million).
- Direct costs account for 48% and indirect costs for 52% of total expenses, with no data on informal care costs.
- The study highlights the neglected role of sleep health in public health strategies despite high prevalence and costs.
- More research on the burden of sleep disorders is needed.